Drug Type Small molecule drug |
Synonyms Imitrodast sodium (JAN), Logran + [3] |
Target |
Action inhibitors |
Mechanism TXA2 synthase inhibitors(Thromboxane A2 synthase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC13H12N2NaO2S |
InChIKeyPLWYYRJTTTZSBZ-UHFFFAOYSA-N |
CAS Registry113817-57-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09774 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arterial thrombosis | NDA/BLA | Japan | - | |
Asthma | NDA/BLA | Japan | - | |
Coronary Vasospasm | NDA/BLA | Japan | - |